NCT04903405Unknown不适用
Immune Function Monitoring and Immunotherapy in Sepsis: a Cross-sectional Survey in China
Sun Yat-sen University0 个研究点目标入组 5,000 人开始时间: 2021年6月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 5,000
- 主要终点
- 28-day mortality
研究概览
简要总结
At present, the clinical studies of various anti-inflammatory drugs and immune-enhancing drugs show that immunotherapy will bring new hope for the treatment of sepsis. In order to further understand the current status of immunotherapy in China, this study aims to understand the current status and standardization of the use of sepsis immunosurveillance and immunotherapy in hospitals through a cross-sectional survey.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with sepsis or septic shock according to Sepsis 3.0
排除标准
- 未提供
结局指标
主要结局
28-day mortality
时间窗: 28 days
次要结局
- Percentage of sepsis patients receiving immune function monitoring(28 days)
- Percentage of sepsis patients receiving immunotherapy(28 days)
研究者
Wu Jianfeng
chief physician
Sun Yat-sen University
相似试验
尚未招募
Unknown
EFFECT Trial: Evaluating Fermentable Fibre as a Long COVID TherapyACTRN12624000356561Monash University40
已完成
不适用
Study of the Efficacy and Safety of Combined Treatment of Patients With Severe Herpes Simplex (HSV) Infection by Valacyclovir and Interferon Inducer KagocelHerpesHerpes OralHerpes Simplex 2Herpes GenitalisHerpes SimplexNCT04664127Nearmedic Plus LLC45
已完成
不适用
Immunogenicity and Safety Evaluation of Recombinant Novel Coronavirus Vaccine (CHO Cells) in Enhancing ImmunityCoronavirus Disease 2019NCT05089045Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.360
进行中（未招募）
4 期
Immunosuppressant Combined With Pirfenidone in CTD-ILDPirfenidoneConnective Tissue DiseasesInterstitial Lung DiseaseNCT04928586Qilu Hospital of Shandong University200
招募中
不适用
Study for the Multidimensional Analyses of Resistance and Toxicity to Immune- and Targeted-therapies.Head and Neck CancerUrothelial CarcinomaLiver MetastasesLung MetastasesBreast CancerColorectal CancerLung CancerMelanomaNCT06321640European Institute of Oncology265